{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:32:21Z","timestamp":1793367141539,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015459","name":"Danish Cancer Society Research Center","doi-asserted-by":"publisher","award":["R269-A15406"],"award-info":[{"award-number":["R269-A15406"]}],"id":[{"id":"10.13039\/100015459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annalsofoncology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.annonc.2026.09.014","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:39:25Z","timestamp":1791319165000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of cryotherapy in preventing taxane-induced neuropathy: the CryoPac randomised controlled trial"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8165-9653","authenticated-orcid":false,"given":"M.E.","family":"Lendorf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.B.","family":"Bille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0023-8011","authenticated-orcid":false,"given":"S.M.","family":"Krog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3584-7246","authenticated-orcid":false,"given":"F.L.","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2595-2751","authenticated-orcid":false,"given":"L.M.","family":"Heining","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.W.","family":"Juul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gravesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Winther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.V.","family":"Frandsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.V.","family":"Lendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Dan\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Knoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0309-1086","authenticated-orcid":false,"given":"H.","family":"Pia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8495-9769","authenticated-orcid":false,"given":"H.","family":"Tankisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Birk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.B.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.annonc.2026.09.014_bib1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1200\/JCO.2007.11.3787","article-title":"Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials","volume":"26","author":"De Laurentiis","year":"2008","journal-title":"J Clin Oncol"},{"issue":"34","key":"10.1016\/j.annonc.2026.09.014_bib2","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1200\/JCO.2006.06.5391","article-title":"Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer","volume":"24","author":"Jones","year":"2006","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.annonc.2026.09.014_bib3","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.2003.02.063","article-title":"Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer","volume":"21","author":"Henderson","year":"2003","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.annonc.2026.09.014_bib4","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.20.03399","article-title":"Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline","volume":"39","author":"Korde","year":"2021","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.annonc.2026.09.014_bib5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrneurol.2010.160","article-title":"Chemotherapy-induced peripheral neurotoxicity","volume":"6","author":"Cavaletti","year":"2010","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.annonc.2026.09.014_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10549-013-2728-2","article-title":"Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer","volume":"142","author":"Eckhoff","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.annonc.2026.09.014_bib7","first-page":"419","article-title":"Chemotherapy-induced peripheral neurotoxicity: a critical analysis","volume":"63","author":"Park","year":"2013","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"10.1016\/j.annonc.2026.09.014_bib8","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis","volume":"155","author":"Seretny","year":"2014","journal-title":"Pain"},{"issue":"18","key":"10.1016\/j.annonc.2026.09.014_bib9","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"32","author":"Hershman","year":"2014","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.annonc.2026.09.014_bib10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/annonc\/mds329","article-title":"The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings","volume":"24","author":"Cavaletti","year":"2013","journal-title":"Ann Oncol"},{"issue":"suppl 5","key":"10.1016\/j.annonc.2026.09.014_bib11","first-page":"S1","article-title":"NCCN task force report: management of neuropathy in cancer","volume":"7","author":"Stubblefield","year":"2009","journal-title":"J Natl Compr Cancer Netw"},{"issue":"28","key":"10.1016\/j.annonc.2026.09.014_bib12","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.annonc.2026.09.014_bib13","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.annonc.2020.07.003","article-title":"Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up","volume":"31","author":"Jordan","year":"2020","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.annonc.2026.09.014_bib14","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1200\/JOP.2012.000863","article-title":"Impact of chemotherapy-induced peripheral neuropathy on treatment delivery in nonmetastatic breast cancer","volume":"9","author":"Speck","year":"2013","journal-title":"J Oncol Pract"},{"issue":"5","key":"10.1016\/j.annonc.2026.09.014_bib15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/oxfordjournals.annonc.a059220","article-title":"Paclitaxel-induced neuropathy","volume":"6","author":"Postma","year":"1995","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.annonc.2026.09.014_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000499599","article-title":"Prevention and management of chemotherapy-induced polyneuropathy","volume":"14","author":"Jordan","year":"2019","journal-title":"Breast Care (Basel)"},{"issue":"2","key":"10.1016\/j.annonc.2026.09.014_bib17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/jnci\/djx178","article-title":"Effects of cryotherapy on objective and subjective symptoms of paclitaxel-induced neuropathy: prospective self-controlled trial","volume":"110","author":"Hanai","year":"2018","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.annonc.2026.09.014_bib18","first-page":"3461","article-title":"Cold therapy to prevent paclitaxel-induced peripheral neuropathy","volume":"26","author":"Griffiths","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.annonc.2026.09.014_bib19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3389\/fonc.2016.00274","article-title":"Limb hypothermia for preventing paclitaxel-induced peripheral neuropathy in breast cancer patients: a pilot study","volume":"6","author":"Sundar","year":"2017","journal-title":"Front Oncol"},{"issue":"16","key":"10.1016\/j.annonc.2026.09.014_bib20","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000033580","article-title":"Persistent weekly paclitaxel-induced peripheral neuropathy in early breast cancer patients enrolled in a randomized trial of cryotherapy","volume":"102","author":"Shigematsu","year":"2023","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.annonc.2026.09.014_bib21","first-page":"5005","article-title":"Cryotherapy for the prevention of weekly paclitaxel-induced peripheral adverse events in breast cancer patients","volume":"28","author":"Shigematsu","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.annonc.2026.09.014_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.breast.2019.09.011","article-title":"Randomized controlled trial of cryotherapy to prevent paclitaxel-induced peripheral neuropathy (RU221511I); an ACCRU trial","volume":"48","author":"Ruddy","year":"2019","journal-title":"Breast"},{"key":"10.1016\/j.annonc.2026.09.014_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.604688","article-title":"Impact of cryotherapy on sensory, motor, and autonomic neuropathy in breast cancer patients receiving paclitaxel: a randomized, controlled trial","volume":"11","author":"Ng","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.annonc.2026.09.014_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.breast.2019.12.011","article-title":"Comparison of the efficacy of cryotherapy and compression therapy for preventing nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a prospective self-controlled trial","volume":"49","author":"Kanbayashi","year":"2020","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.annonc.2026.09.014_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.annonc.2019.09.006","article-title":"Multicenter randomized controlled trial to evaluate the efficacy and tolerability of frozen gloves for the prevention of chemotherapy-induced peripheral neuropathy","volume":"31","author":"Beijers","year":"2020","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.annonc.2026.09.014_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10549-023-07172-y","article-title":"Randomized adaptive selection trial of cryotherapy, compression therapy, and placebo to prevent taxane-induced peripheral neuropathy in patients with breast cancer","volume":"204","author":"Accordino","year":"2024","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"10.1016\/j.annonc.2026.09.014_bib27","first-page":"554","article-title":"Prevention of taxane chemotherapy-induced nail changes and peripheral neuropathy by application of extremity cooling: a prospective single-centre study with intrapatient comparison","volume":"32","author":"Johnson","year":"2024","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.annonc.2026.09.014_bib28","doi-asserted-by":"crossref","first-page":"S1257","DOI":"10.1016\/j.annonc.2022.07.1646","volume":"33","author":"Michel","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.annonc.2026.09.014_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104244","article-title":"Cryotherapy for prevention of chemotherapy induced peripheral neuropathy in breast cancer","volume":"194","author":"Tandon","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"10.1016\/j.annonc.2026.09.014_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.soncn.2024.151673","article-title":"Distal-extremity cryotherapy in preventing chemotherapy-induced peripheral neuropathy from paclitaxel administration in people affected by breast cancer: a systematic review","volume":"40","author":"Ford","year":"2024","journal-title":"Semin Oncol Nurs"},{"issue":"1","key":"10.1016\/j.annonc.2026.09.014_bib31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/1078155220959431","article-title":"Cryotherapy for the prevention of chemotherapy-induced peripheral neuropathy: a systematic review","volume":"27","author":"Bailey","year":"2021","journal-title":"J Oncol Pharm Pract"},{"issue":"19","key":"10.1016\/j.annonc.2026.09.014_bib32","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1200\/JCO.2005.15.651","article-title":"Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand","volume":"23","author":"Scott\u00e9","year":"2005","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.annonc.2026.09.014_bib33","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/cncr.23333","article-title":"Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot","volume":"112","author":"Scott\u00e9","year":"2008","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.annonc.2026.09.014_bib34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1085-9489.2006.00078.x","article-title":"Multi-center assessment of the total neuropathy score for chemotherapy-induced peripheral neurotoxicity","volume":"11","author":"Cavaletti","year":"2006","journal-title":"J Peripher Nerv Syst"},{"issue":"3","key":"10.1016\/j.annonc.2026.09.014_bib35","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1529-8027.2007.00141.x","article-title":"The total neuropathy score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale","volume":"12","author":"Cavaletti","year":"2007","journal-title":"J Peripher Nerv Syst"},{"issue":"8","key":"10.1016\/j.annonc.2026.09.014_bib36","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1212\/WNL.53.8.1660","article-title":"Total neuropathy score: validation and reliability study","volume":"53","author":"Cornblath","year":"1999","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.annonc.2026.09.014_bib37","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/annonc\/mdh348","article-title":"Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy","volume":"15","author":"Cavaletti","year":"2004","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.annonc.2026.09.014_bib38","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1212\/01.WNL.0000092015.03923.19","article-title":"Grading of chemotherapy-induced peripheral neurotoxicity using the total neuropathy scale","volume":"61","author":"Cavaletti","year":"2003","journal-title":"Neurology"},{"issue":"1-2","key":"10.1016\/j.annonc.2026.09.014_bib39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jpain.2019.06.011","article-title":"Quantification of small fiber neuropathy in chemotherapy-treated patients","volume":"21","author":"Timmins","year":"2020","journal-title":"J Pain"},{"issue":"7","key":"10.1016\/j.annonc.2026.09.014_bib40","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.clinph.2017.04.009","article-title":"Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer","volume":"128","author":"Kandula","year":"2017","journal-title":"Clin Neurophysiol"},{"issue":"1","key":"10.1016\/j.annonc.2026.09.014_bib41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pcd.2013.04.004","article-title":"Evaluation of clinical tools and their diagnostic use in distal symmetric polyneuropathy","volume":"8","author":"Pourhamidi","year":"2014","journal-title":"Prim Care Diabetes"},{"issue":"12","key":"10.1016\/j.annonc.2026.09.014_bib42","first-page":"4771","article-title":"Chemotherapy-induced peripheral neuropathy-patient-reported outcomes compared with NCI-CTCAE grade","volume":"27","author":"Tan","year":"2019","journal-title":"Support Care Cancer"},{"issue":"10","key":"10.1016\/j.annonc.2026.09.014_bib43","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1007\/s11136-013-0379-8","article-title":"Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire","volume":"22","author":"Lavoie Smith","year":"2013","journal-title":"Qual Life Res"},{"issue":"8","key":"10.1016\/j.annonc.2026.09.014_bib44","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.ejca.2005.02.012","article-title":"The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20","volume":"41","author":"Postma","year":"2005","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.annonc.2026.09.014_bib45","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"issue":"suppl 4","key":"10.1016\/j.annonc.2026.09.014_bib46","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/S0959-8049(01)00448-8","article-title":"Quality of life research within the EORTC\u2013the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer","volume":"38","author":"Fayers","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.annonc.2026.09.014_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"2","key":"10.1016\/j.annonc.2026.09.014_bib48","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"1","key":"10.1016\/j.annonc.2026.09.014_bib49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jdiacomp.2003.12.006","article-title":"Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening","volume":"19","author":"Kamei","year":"2005","journal-title":"J Diabetes Complications"},{"issue":"2","key":"10.1016\/j.annonc.2026.09.014_bib50","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0894-1130(12)80292-4","article-title":"Testing sensibility, including touch-pressure, two-point discrimination, point localization, and vibration","volume":"6","author":"Bell-Krotoski","year":"1993","journal-title":"J Hand Ther"},{"issue":"6","key":"10.1016\/j.annonc.2026.09.014_bib51","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1370\/afm.1016","article-title":"Accuracy of monofilament testing to diagnose peripheral neuropathy: a systematic review","volume":"7","author":"Dros","year":"2009","journal-title":"Ann Fam Med"},{"issue":"5","key":"10.1016\/j.annonc.2026.09.014_bib52","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1464-5491.2002.00698.x","article-title":"The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort","volume":"19","author":"Abbott","year":"2002","journal-title":"Diabet Med"},{"issue":"4","key":"10.1016\/j.annonc.2026.09.014_bib53","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.pcd.2013.07.001","article-title":"Monofilament insensitivity and small and large nerve fiber symptoms in impaired fasting glucose","volume":"7","author":"Ylitalo","year":"2013","journal-title":"Prim Care Diabetes"},{"issue":"3","key":"10.1016\/j.annonc.2026.09.014_bib54","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.pain.2010.07.026","article-title":"Reference data for quantitative sensory testing (QST): refined stratification for age and a novel method for statistical comparison of group data","volume":"151","author":"Magerl","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.annonc.2026.09.014_bib55","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.pain.2006.01.041","article-title":"Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values","volume":"123","author":"Rolke","year":"2006","journal-title":"Pain"},{"issue":"11","key":"10.1016\/j.annonc.2026.09.014_bib56","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jocn.2009.03.010","article-title":"An assessment of vibration threshold using a biothesiometer compared to a C128-Hz tuning fork","volume":"16","author":"Temlett","year":"2009","journal-title":"J Clin Neurosci"},{"issue":"8","key":"10.1016\/j.annonc.2026.09.014_bib57","first-page":"3763","article-title":"Effect of cryotherapy on dose of adjuvant paclitaxel in early-stage breast cancer","volume":"28","author":"Rosenbaek","year":"2020","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.annonc.2026.09.014_bib58","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4103\/apjon.apjon-2075","article-title":"Cold application and exercise on development of peripheral neuropathy during taxane chemotherapy in breast cancer patients: a randomized controlled trial","volume":"8","author":"\u015eim\u015fek","year":"2021","journal-title":"Asia Pac J Oncol Nurs"},{"issue":"4","key":"10.1016\/j.annonc.2026.09.014_bib59","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jamaoncol.2025.0001","article-title":"Efficacy of hand cooling and compression in preventing taxane-induced neuropathy: the POLAR randomized clinical trial","volume":"11","author":"Michel","year":"2025","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.annonc.2026.09.014_bib60","first-page":"93","article-title":"Impact of cold therapy on paclitaxel-induced peripheral neuropathy and quality of life in patients with breast cancer","volume":"26","author":"Jue","year":"2022","journal-title":"Clin J Oncol Nurs"},{"issue":"1","key":"10.1016\/j.annonc.2026.09.014_bib64","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdt409","article-title":"Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin","volume":"25","author":"Alberti","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.annonc.2026.09.014_bib61","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40780-016-0067-2","article-title":"The effectiveness of regional cooling for paclitaxel-induced peripheral neuropathy","volume":"2","author":"Sato","year":"2016","journal-title":"J Pharm Health Care Sci"},{"issue":"8","key":"10.1016\/j.annonc.2026.09.014_bib62","first-page":"3691","article-title":"Safety and tolerability of cryocompression as a method of enhanced limb hypothermia to reduce taxane-induced peripheral neuropathy","volume":"28","author":"Bandla","year":"2020","journal-title":"Support Care Cancer"},{"issue":"12","key":"10.1016\/j.annonc.2026.09.014_bib63","first-page":"1361","article-title":"Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings","volume":"90","author":"Argyriou","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375342606775X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375342606775X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:44:50Z","timestamp":1793364290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375342606775X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":64,"alternative-id":["S092375342606775X"],"URL":"https:\/\/doi.org\/10.1016\/j.annonc.2026.09.014","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of cryotherapy in preventing taxane-induced neuropathy: the CryoPac randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"Annals of Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annonc.2026.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}]}}